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Abstract: The starfish Narcissia canariensis harvested from the coasts off Dakar, Senegal, 
was investigated for glycolipids (GL). This report deals with the isolation, characterization 
and biological activity of a fraction F13-3 separated from the GL mixture and selected 
according to its ability to inhibit KB cell proliferation after 72 hours of treatment. Firstly, a 
GL mixture F13 was obtained that accounted for 1.36% of starfish biomass (dry weight) 
and  0.36%  of  total  lipids.  The  fraction  F13-3  obtained  from  F13  contained  three 
homologous  GL  identified  as  peracetylated  derivatives  on  the  basis  of  chemical  and 
spectroscopic  evidence.  These  contained  a  β-glucopyranoside  as  sugar  head,  a  
9-methyl-branched  4,8,10-triunsaturated  long-chain  aminoalcohol  as  sphingoid  base  and 
amide-linked  2-hydroxy  fatty  acid  chains.  The  majority  (63%)  had  an  amide-linked 
2-hydroxydocosanoic acid  chain  and was  identified as  the ophidiacerebroside-C, firstly 
isolated  from  the  starfish  Ophidiaster  ophidiamus.  The  minor  components  of  F13-3 
differed  by  one  more  or  one  less  methylene  group,  and  corresponded  to 
ophidiacerebroside-B  and  -D.  We  found  that  F13-3  displayed  an  interesting  cytotoxic 
activity over 24 hours on various adherent human cancerous cell lines (multiple myeloma, 
colorectal adenocarcinoma and glioblastoma multiforme) with an IC50 of around 20 μM. 
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1. Introduction 
Nowadays, myeloma, glioblastoma and carcinomas are a real public health problem in the world 
with increasing mortality rates in developing countries. 
Multiple  myeloma  (MM)  is  a  cancer  of  the  white  blood  cells  known  as  plasma  cells;  it  is 
characterized by skeletal destruction, renal failure, anemia and hypercalcemia. Despite progress in the 
management  of  patients,  MM  remains  an  incurable  disease,  with  a  five-year  survival  rate  not 
exceeding 50%. Recent advances in the understanding of the pathobiology of multiple myeloma (MM) 
have provided the basis for a more comprehensive effort to develop novel therapies for this disease [1,2]. 
As myeloma cells develop mechanisms of resistance to most known treatments [3], the search for new 
efficient anti-cancerous compounds is needed. 
Glioblastoma is the most common and most aggressive type of primary brain tumor in humans, 
involving glial cells. Glioblastoma multiforme (GBM) is the highest grade glioma (grade 4) tumor and 
the most malignant form of astrocytomas. In most European and North American countries, incidence 
is approximately 2–3 new cases per 100,000 people per year. This malignancy of the central nervous 
system is fatal despite treatment with surgery and adjuvant therapy. In the United States, GBM occurs 
at a frequency of approximately  5000  cases  annually, and constitutes up to 80% of all malignant 
gliomas. Long-term control of these tumors is rarely achieved, despite surgical resection and external 
beam radiation therapy, and GBM recurs within 6–10 months with a median survival of approximately 
12 months [4]. 
Carcinomas are invasive malignant tumors consisting of transformed cells arising from epithelial 
origin. Epithelial cells cover the external surface of the body, line the internal cavities and form the 
lining of glandular tissues. Carcinomas are classified by their histopathogical appearance referring to 
the putative cell of origin or primary organ. With more than 600,000 deaths worldwide per  year, 
colorectal  carcinoma  is  the  fourth  most  common  form  of  cancer  in  the  United  States  while 
approximately 36,000 persons will be newly diagnosed with oral cancer in 2010 [5]. 
Glycosphingolipids  (GSL)  are  ubiquitous  membrane  constituents  in  animals,  which  play  a 
fundamental role in major phenomena such as cell-cell recognition and antigenic specificity [6,7]. In 
general GSL exhibit a wide range of biological functions that might be related to the amphipathic 
nature of the molecule. Several GSL and other various glycolipids (GL) have been isolated from a 
number  of  marine  sources,  mainly  including  sponges  and  echinoderms.  Glycolipids  are  known  to 
possess immunomodulating and antitumor activity in particular those isolated from sponges [6–9]. Mar. Drugs 2010, 8  
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Among them, GSL represent a large group of biomolecules containing two basic structural units: a 
sugar  linked  to  a  ceramide.  The  hydrophobic  ceramide  portion  involves  a  sphingoid  base  and  an 
amide-linked fatty acyl chain. Various cerebrosides, glycosylceramides with a single sugar head, were 
isolated from sponges [6–9], tunicates [10], octocorals [11], and echinoderms [12–25]. The phylum 
Echinodermata comprises approximately 7000 living species and their cerebrosides in particular have 
been chemically studied but little is known regarding their biological and pharmacological properties.  
In  the  search  for  new  efficient  GL  against  cancer,  we  investigated  a  not  yet  studied  starfish, 
Narcissia  canariensis,  harvested  off  Dakar,  Senegal.  This  paper  reports  on  the  isolation  of  a  GL 
fraction containing particular GSL named ophidiacerebrosides and the evaluation of their cytotoxic 
activity against various human cancer cell lines. 
2. Results and Discussion 
2.1. Glycolipid Isolation and Structure Determination 
The common African starfish Narcissia canariensis was investigated for lipids and GL fractions. 
The lipid extract (8.97 g) obtained with CH2Cl2/MeOH was subjected to lipid class separation by 
column chromatography affording a crude GL fraction (0.92 g). A subsequent column chromatography 
enabled  obtaining  a  bioactive  GL  fraction  named  F13  selected  for  its  ability  to  inhibit  KB  cell 
proliferation  significatively.  The  F13  fraction  was  in  turn  subjected  to  a  further  preparative 
chromatography that enabled obtaining a purified GL fraction named F13-3 as a white amorphous 
powder. It showed a single spot on thin layer chromatography with an Rf value similar to that of a 
commercial standard galactocerebroside with a hydroxylated acyl chain. Interestingly, fraction F13 
represented 1.36% of the starfish biomass (dry weight), 0.36% of total lipids and 3.58% of the total 
GL. Fraction F13-3 contained a major GSL (63%) and two minor homologous ones as shown by NMR 
and mass spectrometry studies. Thus, the peracetylated F13-3 exhibited the characteristic signals of a 
sphingoid base and a -glucopyranose in the 
1H-NMR spectrum (Figure 1, Table 1). Its electrospray 
ionization  mass  spectrometry  (ESI)  showed  three  molecular  ion  peaks,  corresponding  to  three 
glycosylceramides  with  three  different  -hydroxylated  fatty  acyl  chains.  Indeed,  the  peracetylated 
major GSL component displayed an adduct ion [M + Na]
+ at m/z 1084.6880 (high resolution ESI) in 
accordance with the formula C59H99NO15Na (a molecular mass of 809.7 amu for the intact GSL). The 
minor GSL of peracetylated F13-3 displayed sodiated molecular ions at m/z 1070.6702 and 1098.7051 
in accordance with a methylene less or more than the major one. The structure of the major cerebroside 
was determined on the basis of chemical and spectroscopic evidence. Thus, this glycosylceramide 
contains a triunsaturated long-chain aminoalcohol as the principal sphingoid base. The optical rotation 
value of peracetylated F13-3 was determined as [ʱ]D
30 = +0.44 (c = 0.4, CH2Cl2). Mar. Drugs 2010, 8  
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Figure  1. Glucosylceramides for Narcissia canariensis: ophidiacerebroside-B (n = 16), 
ophidiacerebroside-C (n = 17) and ophidiacerebroside-D (n = 18). 
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Table 1. 
1H, 
13C and COSY NMR spectroscopy data for peracetylated F13-3 glycolipids  
in CDCl3. 
Position  δH ppm, mult., J in Hz  δC ppm  COSY correlation 
NH  6.35 (d, J = 9.0)  -   
1a  3.95 (dd, J = 10.0/3.8)  67.2  2, 1b 
1b  3.62 (dd, J = 10.0/3.8)  67.2  2, 1a 
2  4.32 (m)  72.7  1a, 1b, 3, NH 
3  4.27 (d, J = 4.6)  50.6  4, 2 
4  5.34 (m)  128.7  3, 5  
5  5.43 (dd, J = 6.5/15.0)  124.8  4, 6 
6  2.07 (s)  32.3  5, 7 
7  2.20 (s)  31.9  6, 8, 19 
8  5.83 (m)  136.4  7 
9  -  134.2   
10  6.04 (d, J = 15.4)  134.4  11 
11  5.59 (m)  127.8  10, 12 
12  2.10 (m)  32.9  11, 13 
19  1.73 (s)  12.5  7, 8 
CH2  1.27 (m)  22.7–29.7   
CH3 acetates  2.02/2.04/2.05/2.08/2.11/2.19 (6s)  20.6–21.0   
C=O acetates    169.3/169.4/169.6/160.7
/169.8/169.9 
 
terminal CH3  0.90 (t, J = 6.8)  14.1   
1′  4.49 (d, J = 7.9)  100.5  2′ 
2′  4.97 (dd, J = 8.0/9.5)  71.2  1′, 3′ 
3′  5.20 (t, J = 9.5)  72.7  2′, 4′ 
4′  5.10 (t, J = 9.7)  68.2  3′, 5′ 
5′  3.71 (m)  71.9  4′, 6′a, 6′b 
6′a  4.24 (d, J = 4.5)  61.8  5′, 6′b 
6′b  4.16 (dd, J = 12.5/2.3)  61.8  5, 6a 
1″  -  172.2   
2″  5.36 (m)  73.0   
3″  1.83 (m)  31.8   
4″  1.40 (m)  29.5   
terminal CH3  0.83 (m)  14.1   Mar. Drugs 2010, 8  
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All the chemical shifts of the ceramide are given in the 
13C and 
1H NMR spectra (Table 1). The 
sugar linked to the ceramide was identified as glucose by NMR spectroscopy. First of all, the anomeric 
proton of the β-glucopyranoside (ʴ = 4.49, d, J = 7.9 Hz) was correlated with the anomeric carbon at 
ʴ = 100.5 ppm in the HMQC spectrum. Starting from this proton, all the 
1H and 
13C NMR signals of 
the sugar were assigned by using the COSY, HMQC and HMBC spectra, and the vicinal proton-proton 
coupling constants were determined (Table 1). The gluco configuration of the sugar, as well as its 
β anomeric  configuration,  was  established  on  the  basis  of  the  ring  proton  coupling  constants 
(J1,2 = 7.9 Hz, J2,3 = 9.5 Hz, J3,4 and J4,5 = 9.6 Hz). The linkage of the glucopyranoside to the ceramide 
was confirmed by the three bond 
13C-
1H couplings of anomeric C-1′ with H-1a and H-1b observed in 
the HMBC spectrum. The presence of signals for five olefinic protons and the singlet at ʴ = 1.73 ppm 
indicated that a methyl branch is linked to an olefinic carbon atom. The unsaturation pattern in the 
1H NMR spectrum showed a multiplet at 5.34 ppm and a double doublet at 5.43 ppm, characteristic of 
a Δ
4 sphingosine with trans configuration (J = 15.0 Hz), a doublet at 6.04 ppm (J = 15.4 Hz) for 
a trans  Δ
10  double  bond,  and  multiplets  at  ʴ  5.59,  5.83  ppm.  COSY  correlations  were  observed 
between H-7 and H-8 and H-19 (Table 1). Further correlations were observed between olefinic signals 
at ʴ 5.83 (H-8) and 5.59 (H-11), and vicinal methylene groups at positions 7 and 12. And also we 
observed no correlation between the olefinic carbon C-9 and an olefinic proton in the HSQC spectrum. 
The key HMBC correlations from H3-19 to C-8, C-9, and C-10, and from C-11 to C-9, confirmed the 
location of the positions of the double bonds. These data allowed us to establish the olefinic pattern of 
the sphingoid unit as a 9-methyl-4,8,10-triene. 
To determine the structure of the ceramide, F13-3 was subjected to an acidic methanolysis and the 
resulting reaction mixture was separated by partitioning between CH2Cl2 and H2O/MeOH into an 
aqueous phase containing methylglycosides and an organic phase containing 2-hydroxylated fatty acid 
methyl esters (FAME) and sphingoid bases. Thereafter the latter mixture was analyzed by GC/MS. 
Only one sphingoid base was observed. 
The FAME mixture from the active fraction F13 was analyzed by GC-MS. The 2-hydroxy FAME 
produced the characteristic ions at m/z 90 (McLafferty) and m/z 103. The results were as follows:  
2-OH-21:0, tR = 33.9 min (15.4%), m/z 356 (M
+); 2-OH-22:0, tR = 36.4 min (63.6%), m/z 370 (M
+);  
2-OH-23:0, tR = 38.8 min (21.0%), m/z 384 (M
+). These fatty acid structures were confirmed by 
GC-MS  analysis  of  N-acyl  pyrrolidides  showing  fragment  ions  at  m/z  129  (McLafferty)  and  the 
expected molecular ions. The peracetylated methylglycoside from F13-3 was analyzed by GC-MS 
(column temperature 110 ° C (2 min) and then (temp. increasing at 3 ° C/min until 240 ° C)); tR = 31.6 min 
(methylglucopyranoside) similar to that of an authentic sample. Other diagnostic ions were observed at 
m/z 331 (M-OMe)
+, 303 (M-OAc)
+, 243, 200, 157, 145 and 115. 
These data showed that F13-3 contained a ceramide composed of the known 4,8,10-triunsaturated, 
9-methyl branched C18 sphingoid base and 2-hydroxylated fatty acyl chains like cerebrosides isolated 
from other invertebrates [8,10,11] including starfish [16,19,20,22,25]. 
2.2. Cytotoxic Activity 
The cytotoxic activity of F13-3, including ophidiacerebroside-C as major component, was detected 
and followed using KB cells (human oral epidermoid carcinoma) (IC50: around 20 μM after 72 h of Mar. Drugs 2010, 8  
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treatment). Thereafter it was investigated on three human cancerous cell lines, KMS-11 (adherent 
plasma cells obtained from patients with multiple myeloma [26]), GBM (astrocytoma cells obtained 
after tumor resection of patients with glioblastoma multiforme-primary culture [27]), and HCT-116 
(colorectal adenocarcinoma cells derived from a patient with Lynch’s syndrome [28] and as described 
in the experimental section). Results are shown in Table 2. 
Table 2. IC50 measures for F13-3 (μM ± S.E., 24 h of treatment). 
IC50  KMS-11  HCT-116  GBM 
F13-3  15.2 ±  4.0  18 ±  3.9  34.6 ±  5.1 
The activities observed, mainly on KMS-11 and HCT-116, are interesting as ophidiacerebrosides 
have not yet been evaluated on human cancer cells. Cytotoxicity on these three cell lines was already 
found in the same range of concentration for some synthetic bile acid derivatives (LD50: 8.5 μM) in a 
recent study [29]. A mixture of ophidiacerebrosides with C20 to C24 2-hydroxyacyl chains, including 
the major ophidiacerebroside-C with an acyl chain C22 occurring at 40%, has been described to display 
strong cytotoxicity against L1210 murine leukemia cells in vitro [16]. Cerebrosides isolated from a 
tunicate, phalluside-1 and -2, contain the same triunsaturated sphingoid base and sugar head, but they 
differ in 2-hydroxyacyl chain lengths, C16 and C18 respectively. Interestingly, the latter cerebrosides 
were found inactive against human cancer cells including lung carcinoma (A 549), colon carcinoma 
(HT 29), and melanoma (MEL 28) [10]. In addition, cerebrosides named renierosides with the same 
sphingoid base and various monounsaturated 2-hydroxylated fatty acyl chains were found inactive 
against  five  human  solid  tumor  cell  lines  [8].  These  results  suggest  that  the  nature  of  the 
2-hydroxylated fatty acyl chain (chain length and possible double bonds) seems to be important for the 
cytotoxic activities of this type of cerebrosides. Recently, it was shown that the nature of the sugar 
residue may be relevant for the biological activity of this type of GSL; those with glucopyranosides 
showing  stronger  cytotoxicity  than  those  with  galactocerebrosides  [25].  Due  to  its  potential 
biological interest,  phalluside-1  found  in  the  ascidian  Phallusia  fumigata  [10],  the  sea  stars 
Allostichaster inaequalis [20] and Cosmasterias lurida [19], has recently been recently synthesized [30]. 
In conclusion, this study provides an additional source (another starfish) for ophidiacerebrosides 
and points out the potential of these compounds against human cancerous cells. It would be of interest 
to investigate other GL fractions of N. canariensis for glycosylceramide isolation, in particular those 
with the same sphingoid base but differing by 2-hydroxylated acyl chain length and to compare their 
cytotoxic activities using the same panel of human cancer cell lines. 
3. Experimental Section 
3.1. General Procedures 
High resolution electrospray ionization mass spectrometry (HR-ESI-MS, positive mode, ion-source 
acceleration 4.5 kV, ion-source temperature 200 ° C, methanol as solvent) mass spectra were recorded 
with a Micromass Zab Spec Tof spectrometer. 
1H- and 
13C-NMR as well as 2D-NMR spectra were 
obtained on a NMR Bruker Avance-500 spectrometer with triple Probe TBI multinuclear in CDCl3 at 
500.13 MHz and 125.76 MHz respectively, with reference to an internal standard of tetramethylsilane. Mar. Drugs 2010, 8  
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Chemical  shifts  and  coupling  constants  were  expressed  in  ʴ  (ppm)  and  Hz  respectively.  GC-MS 
spectra were performed on a Hewlett-Packard 6890 gas chromatograph with a mass selective detector 
MS HP 6890 MS, Little polar column DB-1, 60 m length ×  0.25 mm i.d. ×  0.25 µm phase thickness. 
The temperature of the column was varied, after a delay of 2–4 min from the injection, from 110 to 
310 ° C  with  a slope of 3 ° C  min
−1. Optical  rotations were measured in CH2Cl2 solutions  with a 
Polartronic NH8 Schmidt/Haensch polarimeter at 30 ° C. Analytical TLC was performed on precoated 
silica gel F254 plates. After development, the dried plates were sprayed with 50% H2SO4-vanillin and 
orcinol reagents. 
3.2. Animal Material 
The starfish Narcissia canariensis, shown below in Figure 2 (photo taken by Dr. Patrice Petit de 
Voize, Dakar) is found on rocks along the Senegalese coasts off Dakar, at a depth range of 23–38 m and 
were collected by hand during a scuba diving expedition organized by Oceanium of Dakar in 2009, on 
the sites named Petit Seminole, Fayss and Thi Wa. The specimens were identified by Professor Peter 
Wirtz, University of Madeira, Portugal. 
Figure 2. Narcissia canariensis. 
 
3.3. Lipid Extraction and F13-3 Isolation 
Whole bodies of the collected specimens (241.37 g dry weight) were chopped and twice extracted 
with  CH2Cl2/MeOH (1:1, vol/vol) at  room temperature. The combined extracts  were concentrated 
in vacuo  to  give  the  crude  extract,  which  was  partitioned  between  H2O  and  CH2Cl2/MeOH.  The 
organic layer was concentrated in vacuo, and the residue (8.97 g, 3.7%) was chromatographed on silica 
gel column with pure solvents as successive eluents: Dichloromethane (neutral lipids, 6.30 g), acetone 
(GL, 0.92 g) and methanol (phospholipids, 1.68 g). The GL mixture was separated on silica gel column 
to give 14 fractions. Among them, fraction 1 was subjected to a silica gel column chromatography 
(CH2Cl2/MeOH, 95:5 to 80:20, vol/vol) affording 23 fractions. From the latter fractions, fraction 13 
(F13, 33 mg)  gave a positive test  on KB  cells, and presented  a similar polarity  to a commercial 
standard (galactocerebroside with 2-hydroxy fatty acyl chain type I) (Rf = 0.35 on silica gel thin layer 
chromatography, CH2Cl2/MeOH, 88:12, vol/vol). Then F13 was subjected to silica gel chromatography 
with  a  solvent  system  of  CH2Cl2  with  5%  to  15%  MeOH  vol/vol)  to  give  seven  fractions.  The 
following fraction 3 (21 mg), designated as F13-3, was obtained as a white amorphous powder and Mar. Drugs 2010, 8  
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was  used  for  biological  studies.  In  order  to  determine  the  chemical  structure,  fraction  F13-3  was 
peracetylated and studied by NMR and ESI-MS. 
3.4. Acetylation of F13-3 
A part of F13-3 (9 mg) was dissolved in 1 mL of acetic anhydride and some drops of dry pyridine. 
The reaction was allowed to proceed for 18 h in darkness at room temperature, and then the reaction 
mixture  was  partitioned  between  water  and  dichloromethane.  The  organic  layer  was  washed  with 
HCl 1 M, neutralized with a Na2CO3 solution, and dried on anhydrous sodium sulfate. The solvent was 
evaporated under reduced pressure and the residue was weighed. 
3.5. Methanolysis of F13-3 
A part of F13 (3 mg) was heated with 0.9 mL of MeOH/H2O/HCl (29:4:3, vol/vol/vol) at 80 ° C for 
18  h.  The  reaction  mixture  was  extracted  with  H2O/CH2Cl2 (3:9,  vol/vol),  the  aqueous  layer  was 
concentrated to give methylglycosides, whereas the organic layer contained a mixture of fatty acid 
methyl esters (FAME) and sphingoid bases. A part (1/3) of the FAME was preserved, the other one 
was transformed into N-acylpyrrolidides (NAP) by heating in a mixture pyrrolidine/acetic acid (10:2, 
vol/vol, 1 mL) during 1 h at 85 ° C. The reaction mixture was separated with H2O/CH2Cl2 and the 
organic layer was dried on anhydrous Na2SO4, filtrated and weighed after solvent evaporation. The 
aqueous layer was neutralized by NaOH 1 M and extracted twice with diethyl ether. The organic layer, 
containing  sphingoid  base  was  dried  and  then  acetylated.  The  aqueous  layer  containing 
methylglycosides was evaporated in vacuo and then acetylated before GC-MS analysis. 
3.6. Cell Cultures 
Cells were cultured in RPMI 1640 medium (KMS-11, GBM, HCT-116) or BME (KB) supplemented 
with  10%  foetal  calf  serum,  2  mM  glutamine,  antibiotics  (100  IU/mL  penicillin  and  100  g/mL 
streptomycin) (Life Technologies). Cells were subcultured at confluency after dispersal with 0.025% 
trypsin  in  0.02%  EDTA.  Cells  were  maintained  in  plastic  culture  plate  at  37  °C  in  a  humidiﬁed 
atmosphere containing 5% CO2. For experiments cells were used at 70–80% confluency. 
3.7. Neutral Red Assay 
For cytotoxicity tests, 20,000 cells (GBM, HCT-116) and 50,000 cells (KMS-11) (200 µL) were 
plated in 96-well culture microtiter plates (Falcon) and incubated at 37 ° C in 5% CO2. After 24 h, 
drugs were added in 50 µL fresh medium, then after 21 h cells were loaded for 3 h with neutral red 
(3-amino-7-dimethylamino-2-methylphenazine hydrochloride) (Sigma-Aldrich, St Quentin, France) at 
a final concentration of 50 µg/mL in culture medium. Thereafter (24 h of treatment) the medium was 
removed,  cells  were  fixed  for  5  min  with  a  mixture  of  1%  formaldehyde-1%  CaCl2  and  the  dye 
extracted with  0.2 mL  of 1% acetic acid  in  50% ethanol. Plates  were  left  overnight  at  4 ° C and 
absorbance was recorded at 570 nm (Multiskan EX-Thermo-Electron Corporation). Experiments were 
performed at least in triplicate, 4 wells per F13-3 concentration being used. IC50 (inhibition of cell Mar. Drugs 2010, 8  
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viability of 50%) values were calculated from the dose-response curves, an example is given in Figure 3. 
Statistics: Values are expressed as the mean of three independent experiments ±  standard error. 
Figure 3. Dose-response curve of F13-3 (24 h of treatment). 
 
3.8. MTT Assay 
After trypsinization KB cells were suspended as a 200,000 cells/mL suspension and 50 µL were 
dropped in each well of 96-well microplates (Costar, Corning, NY, U.S.). Tests were performed once 
the cells had settled at the bottom of the wells (48 h cultures) by incorporating 50 µL of test solutions. 
After 72 h of incubation, cell viability was determined using the colorimetric MTT assay according to 
Denizot and Lang [31]. This test was mainly used for the detection and follow-up of active fractions in 
the course of purification. 
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